Implementing innovative AI based systems in pharmaceutical industry is trending, however its uptake in Medical Writing has been challenging due to lack on one bespoke integrated solution. There is a need for industry experts constructing foundations for a platform which reimagines documents as data elements which can be curated to author documents.
Today result documents like Clinical Study Reports (CSR), and other submission documents are authored manually. In addition to inefficiencies for both writers and reviewers in creating routine content based on personal preferences and interpretations, there are also inconsistencies associated with the manual process leading to lower quality with extended timelines. Authoring step is critical to driving faster submission as this is a time-consuming manual step. Using modern software tools and generative AI capabilities strictly regulated for accuracy and consistency will help augment medical writing activities and drive efficiencies.
This poster will discuss challenges and opportunities with creation and implementation of standards, adoption of technical solution and associated change management. Presentation will focus on: Successes and challenges with experience from early adoption of technology in Medical Writing; importance of seamless data flow; importance of change management; potential of AI to aid acceleration of submission and a discussion on the needed skillset and competencies transforming the current roles into specialized ones by having AI perform standard repetitive tasks, thereby allowing subject matter experts focus on the science

Standards and Artificial Intelligence (AI) to accelerate submission documentation – opportunities and challenges

DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2024 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

Join us in the vibrant city of Brussels for an unforgettable experience, where the power of collaboration will be on full display to inspire actionable outcomes and mobilise for solutions the life sciences’ community. Witness first-hand the profound impact of united efforts, gain valuable insights from across the drug development lifecycle, and play an active role in shaping the future of the pharmaceutical arena.

DIA Europe 2024

A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.